Profitability
by Company within Major Pharmaceutical Preparations Industry
|
Company |
Quarter |
Gross Margin |
Net Margin |
Cash flow Margin |
ROE |
Aadi Bioscience Inc |
4 Q |
85.35% |
-257.18% |
-93.5% |
-52.53% |
Abbvie inc |
4 Q |
60.11% |
5.76% |
-3.31% |
40% |
Abcellera Biologics Inc |
4 Q |
- |
-513.73% |
-426.03% |
-12.36% |
Abeona Therapeutics Inc |
3 Q |
- |
-1995.95% |
-255.14% |
-201.46% |
American Bio Medica Corporation |
1 Q |
45.12% |
- |
20.73% |
- |
Abbott Laboratories |
4 Q |
55.51% |
15.56% |
1.83% |
15.53% |
Arbutus Biopharma Corp |
3 Q |
- |
-431.6% |
-207.51% |
-7.82% |
Abvc Biopharma Inc |
3 Q |
-86.44% |
-21204.23% |
- |
-353.64% |
Acadia Pharmaceuticals Inc |
3 Q |
93.09% |
-30.79% |
-5.71% |
-38.84% |
Acer Therapeutics Inc |
3 Q |
77.46% |
-3962.25% |
-257.88% |
- |
Adicet Bio Inc |
3 Q |
- |
- |
- |
-57.66% |
Ac Immune Sa |
4 Q |
- |
-366.41% |
- |
-33.76% |
Aclaris Therapeutics Inc |
4 Q |
95.87% |
-8.49% |
4.77% |
-52.82% |
Acrivon Therapeutics Inc |
3 Q |
- |
- |
- |
-20.66% |
Acasti Pharma Inc |
3 Q |
- |
- |
- |
-54.53% |
Accustem Sciences Inc |
2 Q |
- |
- |
- |
- |
Acurx Pharmaceuticals inc |
4 Q |
- |
- |
- |
-289.68% |
Adc Therapeutics Sa |
4 Q |
96.36% |
-345.11% |
-69.05% |
-780.2% |
Adial Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-234.06% |
Aditxt Inc |
3 Q |
14.11% |
-7828.91% |
- |
- |
Addex Therapeutics Ltd |
4 Q |
- |
-1462.57% |
- |
-312.48% |
Advaxis Inc |
1 Q |
- |
-976% |
-3858% |
-29.54% |
Aeon Biopharma inc |
3 Q |
- |
- |
- |
- |
Aeterna Zentaris Inc |
4 Q |
97.22% |
-402.96% |
- |
-15.79% |
Kaya Holdings Inc |
3 Q |
62.57% |
- |
-110.04% |
- |
Affimed N v |
4 Q |
- |
-207.98% |
- |
-37.62% |
Agex Therapeutics Inc |
2 Q |
44.44% |
-29766.67% |
- |
- |
Agios Pharmaceuticals Inc |
4 Q |
91.75% |
-1350.7% |
- |
-38.08% |
Agile Therapeutics Inc |
3 Q |
67.66% |
-12.92% |
1.41% |
- |
Ainos Inc |
4 Q |
-559.7% |
-29765.38% |
-2438.38% |
-47.95% |
Akebia Therapeutics Inc |
4 Q |
65.45% |
-0.08% |
-6.42% |
- |
Akero Therapeutics Inc |
3 Q |
- |
- |
- |
-26.11% |
Akari Therapeutics Plc |
4 Q |
- |
- |
- |
-991.1% |
Akouos inc |
3 Q |
- |
- |
- |
-45.09% |
Albireo Pharma inc |
3 Q |
93.78% |
-384.46% |
- |
-97.59% |
Aldeyra Therapeutics Inc |
3 Q |
- |
- |
- |
-33.77% |
Alimera Sciences Inc |
4 Q |
85.1% |
-14.19% |
14.16% |
-65.83% |
Alkermes Plc |
3 Q |
83.85% |
12.54% |
-4.75% |
18.33% |
Allakos Inc |
3 Q |
- |
- |
- |
-62.29% |
Allarity Therapeutics Inc |
3 Q |
- |
- |
- |
- |
Alnylam Pharmaceuticals Inc |
4 Q |
83.63% |
-31.35% |
-50.11% |
- |
Alpine Immune Sciences Inc |
3 Q |
- |
-116.72% |
-150.3% |
-33.54% |
Aileron Therapeutics Inc |
3 Q |
- |
- |
- |
-90.99% |
Altimmune inc |
3 Q |
- |
-5710.22% |
-4280.94% |
-46.77% |
Alx Oncology Holdings Inc |
3 Q |
- |
- |
- |
-65.99% |
Alzamend Neuro Inc |
3 Q |
- |
- |
- |
-992.85% |
Amylyx Pharmaceuticals Inc |
3 Q |
94.92% |
20.35% |
-109.55% |
0.49% |
Ampio Pharmaceuticals inc |
3 Q |
- |
- |
- |
-111.36% |
Amphastar Pharmaceuticals Inc |
3 Q |
60.04% |
27.26% |
66.33% |
23.93% |
Amarin Corp Plcuk |
3 Q |
45.15% |
-29.23% |
57.25% |
-9.12% |
Amneal Pharmaceuticals Inc |
4 Q |
30.72% |
-15.11% |
0.57% |
-42.4% |
Applied Molecular Transport Inc |
3 Q |
- |
- |
- |
-223.46% |
Anaptysbio Inc |
4 Q |
- |
-468.75% |
- |
-119.42% |
Anebulo Pharmaceuticals Inc |
4 Q |
- |
- |
- |
-109.4% |
Ani Pharmaceuticals Inc |
4 Q |
59.42% |
0.88% |
21.3% |
4.73% |
Anixa Biosciences Inc |
4 Q |
- |
- |
- |
-41.57% |
Annexon Inc |
3 Q |
- |
- |
- |
-71.47% |
An2 Therapeutics Inc |
3 Q |
- |
- |
- |
-58.99% |
Annovis Bio inc |
3 Q |
- |
- |
- |
-195.55% |
Apexigen Inc |
2 Q |
- |
- |
- |
-910.95% |
Apellis Pharmaceuticals Inc |
3 Q |
- |
-127.03% |
-148.41% |
-209.04% |
Applied Therapeutics inc |
4 Q |
- |
- |
- |
- |
Aprea Therapeutics Inc |
3 Q |
- |
- |
- |
-55.45% |
Aptinyx Inc |
1 Q |
- |
- |
- |
-157.89% |
Aptevo Therapeutics Inc |
3 Q |
- |
- |
- |
-89.48% |
Aquestive Therapeutics Inc |
4 Q |
64.57% |
-61.42% |
-7.91% |
- |
Aravive Inc |
3 Q |
- |
- |
-1639.73% |
- |
Arcturus Therapeutics Holdings Inc |
3 Q |
- |
-35.94% |
-25.58% |
34.11% |
Aridis Pharmaceuticals Inc |
4 Q |
- |
-526.55% |
- |
- |
Ardelyx Inc |
4 Q |
84.85% |
-44.54% |
-23.78% |
-22.33% |
Arcutis Biotherapeutics Inc |
4 Q |
83.39% |
- |
-141.01% |
-3.5% |
Artelo Biosciences Inc |
3 Q |
- |
- |
- |
-56.3% |
Arvinas Inc |
4 Q |
- |
- |
- |
-70.24% |
Arrowhead Pharmaceuticals Inc |
4 Q |
- |
-3812.33% |
-1485.05% |
-92.61% |
Aslan Pharmaceuticals Limited |
4 Q |
- |
- |
- |
-377.64% |
Assembly Biosciences Inc |
3 Q |
- |
- |
- |
-116.42% |
Ascendis Pharma A |
4 Q |
76.28% |
-1139.63% |
- |
-221.45% |
Assertio Holdings inc |
4 Q |
70.53% |
-173.97% |
-10.45% |
-158.86% |
Atai Life Sciences N v |
3 Q |
- |
- |
-74250.57% |
-28.83% |
Alterity Therapeutics Limited |
2 Q |
- |
- |
- |
0% |
Athersys Inc |
3 Q |
- |
- |
- |
- |
180 Life Sciences Corp |
3 Q |
- |
- |
- |
-645.9% |
Actinium Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-91.02% |
Athenex Inc |
4 Q |
75.22% |
-425.38% |
-143.85% |
- |
Atossa Therapeutics Inc |
3 Q |
- |
- |
- |
-27.47% |
Adhera Therapeutics Inc |
2 Q |
- |
- |
- |
- |
Avenue Therapeutics Inc |
3 Q |
- |
- |
- |
- |
Astria Therapeutics inc |
4 Q |
- |
- |
- |
-34.74% |
Aurinia Pharmaceuticals Inc |
4 Q |
88.04% |
-59.6% |
5.5% |
-20.1% |
Avadel Pharmaceuticals Plc |
3 Q |
98.33% |
-517.17% |
26.03% |
-327.66% |
Aveo Pharmaceuticals Inc |
3 Q |
86.98% |
-10.73% |
23.74% |
-81.66% |
Atea Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-21.49% |
Avenir Wellness Solutions Inc |
3 Q |
71.83% |
-216.76% |
1.36% |
- |
Aerovate Therapeutics Inc |
2 Q |
- |
- |
- |
-10.3% |
Avalo Therapeutics Inc |
3 Q |
-4.66% |
-2215.25% |
- |
- |
Axim Biotechnologies Inc |
3 Q |
- |
- |
-775.26% |
- |
Axsome Therapeutics Inc |
3 Q |
88.7% |
-107.62% |
-35.56% |
-104.89% |
Aytu Biopharma Inc |
4 Q |
72.98% |
-0.99% |
-1.96% |
-49.55% |
Astrazeneca Plc |
4 Q |
81.95% |
13.01% |
13.46% |
15.22% |
Azitra Inc |
4 Q |
- |
-2415.62% |
-1281.03% |
- |
Bridgebio Pharma Inc |
3 Q |
85.38% |
-4387.39% |
- |
- |
Atreca inc |
3 Q |
- |
- |
- |
-200.73% |
Briacell Therapeutics Corp |
2 Q |
- |
- |
- |
0% |
Bicycle Therapeutics Plc |
4 Q |
- |
-921.01% |
-856.57% |
-57.8% |
Bioadaptives Inc |
3 Q |
29.71% |
-83.46% |
- |
- |
Biodexa Pharmaceuticals Plc |
4 Q |
- |
-1095.28% |
0% |
-242.13% |
Bullfrog Ai Holdings Inc |
4 Q |
- |
- |
- |
0% |
Biofrontera Inc |
4 Q |
- |
-0.48% |
-5.97% |
-154.77% |
Beigene ltd |
4 Q |
83.44% |
-58.02% |
16.59% |
-23.12% |
Bausch Health Companies Inc |
4 Q |
71.14% |
-1.95% |
7.56% |
-2468.69% |
Biohaven Ltd |
3 Q |
- |
- |
- |
-181.21% |
Biora Therapeutics Inc |
3 Q |
- |
- |
- |
- |
Biovie Inc |
4 Q |
- |
- |
- |
-341.34% |
Bioxytran Inc |
3 Q |
- |
- |
- |
- |
Bellicum Pharmaceuticals Inc |
3 Q |
- |
-76.15% |
-1589.62% |
- |
Bellerophon Therapeutics inc |
3 Q |
- |
- |
- |
-164.63% |
Biolinerx Ltd |
4 Q |
- |
- |
- |
-53.21% |
Belite Bio Inc |
4 Q |
- |
- |
- |
-34.98% |
Biomea Fusion Inc |
3 Q |
- |
- |
- |
-69.97% |
Biomarin Pharmaceutical Inc |
4 Q |
79.03% |
3.15% |
-4.69% |
3.48% |
Bristol myers Squibb Company |
4 Q |
76.08% |
15.35% |
34.43% |
26.26% |
Bionomics Limited |
2 Q |
- |
-144450.3% |
0% |
-96.08% |
Benitec Biopharma Inc |
4 Q |
- |
- |
- |
-204.34% |
Bolt Biotherapeutics Inc |
3 Q |
- |
-643.08% |
-161.83% |
-47.56% |
Blueprint Medicines Corporation |
4 Q |
- |
-142.61% |
19.76% |
-191.56% |
Bio path Holdings inc |
4 Q |
- |
- |
- |
-375.74% |
Bespoke Extracts Inc |
3 Q |
40.26% |
-123.37% |
-0.8% |
- |
Bioxcel Therapeutics Inc |
3 Q |
-50.15% |
-14805.28% |
-11021.7% |
-890.64% |
Blue Water Biotech Inc |
3 Q |
- |
- |
- |
-111.79% |
Baudax Bio Inc |
3 Q |
- |
- |
- |
- |
Beyondspring Inc |
4 Q |
- |
-2685.42% |
-5026.79% |
- |
Calithera Biosciences Inc |
4 Q |
- |
- |
- |
-107.94% |
Calcimedica Inc |
3 Q |
- |
- |
- |
-174.2% |
Calliditas Therapeutics Ab |
4 Q |
98.11% |
-51.35% |
- |
-4.4% |
Can fite Biopharma Ltd |
4 Q |
- |
-1255.93% |
-478.77% |
-224.17% |
Capricor Therapeutics inc |
4 Q |
- |
-6.3% |
47.24% |
-299.65% |
Cara Therapeutics inc |
4 Q |
79.76% |
-1076.46% |
-369.51% |
-122.1% |
Carisma Therapeutics Inc |
3 Q |
- |
-1118.53% |
- |
-96.71% |
Casi Pharmaceuticals inc |
4 Q |
63.28% |
-93.39% |
46.03% |
-90.31% |
Cymabay Therapeutics Inc |
4 Q |
- |
-73512.28% |
-117119.3% |
-50.72% |
Catalyst Biosciences Inc |
3 Q |
- |
- |
- |
- |
Chemocentryx Inc. |
2 Q |
96.59% |
-134.54% |
16.23% |
-48.52% |
Avid Bioservices Inc |
3 Q |
-18.41% |
-37.53% |
24.38% |
-6.11% |
Conduit Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
Celularity Inc |
3 Q |
85.29% |
-2479.56% |
-74.25% |
-144.18% |
Chembio Diagnostics Inc |
4 Q |
45.78% |
-8.27% |
-27.8% |
-113.57% |
Cen Biotech Inc |
3 Q |
- |
-264.15% |
-94.3% |
- |
Cerevel Therapeutics Holdings Inc |
3 Q |
- |
- |
- |
-99.72% |
Contrafect Corporation |
3 Q |
- |
- |
- |
- |
China Health Industries Holdings Inc |
3 Q |
0% |
-476.12% |
-90.8% |
-0.33% |
Cincor Pharma Inc |
3 Q |
- |
- |
- |
0% |
Cingulate Inc |
3 Q |
- |
- |
- |
- |
Checkpoint Therapeutics inc |
3 Q |
- |
-18464.52% |
-33212.9% |
- |
Caladrius Biosciences Inc |
1 Q |
- |
- |
- |
-24.66% |
Cell Source Inc |
2 Q |
- |
- |
- |
- |
Clene Inc |
4 Q |
77.65% |
-5984.12% |
-7818.82% |
-361.99% |
Cellectar Biosciences inc |
3 Q |
- |
- |
- |
-1632.54% |
Clearside Biomedical Inc |
3 Q |
83.47% |
-1078.81% |
-722.12% |
- |
Clever Leaves Holdings Inc |
3 Q |
66.01% |
-174.64% |
47.48% |
-118.25% |
Clovis Oncology inc |
3 Q |
76.31% |
-182.68% |
-118.25% |
- |
Chemomab Therapeutics Ltd |
1 Q |
- |
- |
- |
77.93% |
Clearmind Medicine Inc |
3 Q |
- |
- |
- |
-876.57% |
Compass Pathways Plc |
4 Q |
- |
- |
- |
-58.72% |
Comera Life Sciences Holdings Inc |
3 Q |
69.22% |
-1580.01% |
- |
- |
Chimerix Inc |
4 Q |
- |
-454025% |
- |
-37.93% |
Cnbx Pharmaceuticals Inc |
4 Q |
- |
-199.61% |
-53.72% |
- |
Concert Pharmaceuticals Inc |
3 Q |
- |
-361300% |
-550700% |
-165.03% |
Cns Pharmaceuticals Inc |
3 Q |
- |
-35106.69% |
-26156.21% |
-615.33% |
Centessa Pharmaceuticals Plc |
3 Q |
- |
- |
- |
-54.03% |
Connect Biopharma Holdings Limited |
4 Q |
- |
- |
- |
-72.67% |
Context Therapeutics Inc |
3 Q |
- |
- |
- |
-78.39% |
Cocrystal Pharma Inc |
2 Q |
- |
- |
- |
-51.18% |
Cogent Biosciences Inc |
3 Q |
- |
- |
- |
-62.85% |
Collegium Pharmaceutical Inc |
4 Q |
- |
- |
-459.2% |
25.52% |
Corcept Therapeutics Inc |
4 Q |
98.61% |
23.01% |
17.54% |
21.98% |
Coya Therapeutics Inc |
3 Q |
- |
- |
- |
0% |
China Pharma Holdings Inc |
3 Q |
-12.93% |
-43.12% |
25.95% |
-64.06% |
Cumberland Pharmaceuticals Inc |
4 Q |
83.64% |
-67.38% |
-1.99% |
-18.38% |
Cannapharmarx Inc |
3 Q |
- |
- |
- |
- |
Catalyst Pharmaceuticals Inc |
4 Q |
85.7% |
31.51% |
15.07% |
19.76% |
Corbus Pharmaceuticals Holdings Inc |
3 Q |
- |
- |
- |
-320.25% |
Cormedix Inc |
3 Q |
- |
- |
- |
-65.98% |
Crinetics Pharmaceuticals Inc |
3 Q |
- |
-16606.36% |
- |
-57.04% |
Cervomed Inc |
3 Q |
- |
- |
- |
0% |
Corvus Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-60.76% |
Cti Biopharma Corp |
1 Q |
94.92% |
-55.66% |
-25.75% |
- |
Innovation Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-116.47% |
Catalent Inc |
4 Q |
16.7% |
-20.12% |
1.95% |
-30.92% |
Cytomx Therapeutics Inc |
3 Q |
- |
11.34% |
-119.44% |
- |
Citius Pharmaceuticals Inc |
4 Q |
- |
- |
- |
-42.88% |
Cue Biopharma Inc |
3 Q |
- |
-524.05% |
85.24% |
-99.14% |
Cadrenal Therapeutics Inc |
3 Q |
- |
- |
- |
- |
Cv Sciences Inc |
3 Q |
47.96% |
-11.63% |
-1.22% |
56.96% |
Cohbar Inc |
2 Q |
- |
- |
- |
-88.89% |
Celyad Oncology Sa |
4 Q |
- |
- |
- |
-614.13% |
Cyclacel Pharmaceuticals Inc |
3 Q |
- |
-37387.5% |
-26375% |
-278.19% |
Cyclerion Therapeutics Inc |
1 Q |
- |
-1825.32% |
-1805.34% |
-99.04% |
Cytodyn inc |
4 Q |
- |
- |
- |
- |
Cryoport inc |
4 Q |
40.62% |
-112.45% |
-22.93% |
-20.19% |
Cyteir Therapeutics Inc |
3 Q |
- |
- |
- |
-24.88% |
Cytokinetics Incorporated |
3 Q |
- |
-34238.62% |
- |
- |
Altamira Therapeutics Ltd |
4 Q |
-372.44% |
-8680.31% |
0% |
- |
Dar Bioscience Inc |
3 Q |
- |
-829.91% |
56.53% |
-1482.44% |
Day One Biopharmaceuticals Inc |
3 Q |
- |
- |
- |
-7.66% |
Decibel Therapeutics Inc |
2 Q |
- |
- |
- |
-84.03% |
Deciphera Pharmaceuticals Inc |
4 Q |
96.3% |
-97.71% |
-53.26% |
-49.44% |
Journey Medical Corporation |
3 Q |
81.39% |
48.61% |
22.49% |
-118.05% |
Dice Therapeutics Inc |
2 Q |
- |
- |
- |
-22.01% |
Diamedica Therapeutics Inc |
3 Q |
- |
- |
- |
-41.26% |
Dmk Pharmaceuticals Corporation |
3 Q |
-3635.25% |
-15317.21% |
- |
- |
Dianthus Therapeutics Inc |
3 Q |
- |
-1597.73% |
- |
-61.77% |
Dermata Therapeutics Inc |
3 Q |
- |
- |
- |
-102.71% |
Durect Corp |
3 Q |
82.11% |
-172.88% |
- |
-243.4% |
Bright Minds Biosciences Inc |
3 Q |
- |
- |
- |
-111.73% |
Design Therapeutics Inc |
3 Q |
- |
- |
- |
-23.69% |
Dynavax Technologies Corporation |
3 Q |
80.69% |
20.86% |
-105.46% |
10.46% |
Dyne Therapeutics Inc |
3 Q |
- |
- |
- |
-97.57% |
Emergent Biosolutions Inc |
4 Q |
33.68% |
-19.14% |
8.67% |
-86.78% |
Edesa Biotech Inc |
4 Q |
- |
- |
- |
-103.79% |
Effector Therapeutics Inc |
3 Q |
- |
- |
- |
- |
Eagle Pharmaceuticals inc |
2 Q |
73.92% |
7.99% |
-10.12% |
4.98% |
Elevai Labs Inc |
3 Q |
66.01% |
-141.18% |
-122.25% |
- |
Elanco Animal Health Inc |
4 Q |
50.14% |
-13.62% |
-1.64% |
-18.07% |
Eledon Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-101.74% |
Elite Pharmaceuticals Inc |
1 Q |
47.96% |
33.71% |
17.31% |
40.81% |
Elicio Therapeutics Inc |
3 Q |
- |
- |
- |
-100.2% |
Enliven Therapeutics Inc |
3 Q |
- |
- |
- |
-8.69% |
Eliem Therapeutics Inc |
3 Q |
- |
- |
- |
-33.55% |
Emmaus Life Sciences Inc |
3 Q |
95.74% |
1.34% |
2.87% |
- |
Endo International Plc |
4 Q |
49.87% |
-490.52% |
-9.17% |
- |
Enlivex Therapeutics Ltd |
4 Q |
- |
- |
- |
-54.64% |
Ensysce Biosciences Inc |
4 Q |
- |
- |
-403.22% |
- |
Enanta Pharmaceuticals Inc |
3 Q |
- |
-148.46% |
-51.71% |
-52.23% |
Enveric Biosciences Inc |
3 Q |
- |
- |
- |
-278.69% |
Evolus Inc |
4 Q |
68.41% |
-19.4% |
39.6% |
- |
Essa Pharma inc |
4 Q |
- |
- |
- |
-17.41% |
Epizyme Inc. |
2 Q |
81.22% |
-129.85% |
-23.09% |
- |
Equillium Inc |
3 Q |
- |
-41.83% |
98.74% |
-29.28% |
Eqrx Inc |
3 Q |
- |
- |
- |
-20.27% |
Erasca Inc |
3 Q |
- |
- |
- |
-58.93% |
Eterna Therapeutics Inc |
4 Q |
-288.24% |
-36194.12% |
- |
-508.61% |
Esperion Therapeutics inc |
4 Q |
- |
-174.71% |
-101.04% |
- |
89bio Inc |
3 Q |
- |
- |
- |
-34.92% |
Eton Pharmaceuticals Inc |
4 Q |
47.31% |
-29.41% |
-8.89% |
-6.21% |
Earth Science Tech Inc |
1 Q |
44.24% |
-83.86% |
13.46% |
- |
Entasis Therapeutics Holdings Inc |
1 Q |
- |
- |
- |
-145.48% |
Evofem Biosciences Inc |
3 Q |
63.05% |
- |
-4.42% |
- |
Evelo Biosciences Inc |
3 Q |
- |
- |
- |
- |
Evotec Se |
4 Q |
23.16% |
-23.38% |
56.24% |
-14.8% |
Evoke Pharma Inc |
3 Q |
- |
-108.39% |
-66.65% |
-517.96% |
Edgewise Therapeutics inc |
4 Q |
- |
- |
- |
-32.06% |
Eyenovia inc |
3 Q |
0% |
-612582.05% |
- |
-171.3% |
Fortress Biotech Inc |
3 Q |
81.5% |
-30.86% |
-41.62% |
-1797.17% |
Forte Biosciences Inc |
3 Q |
- |
- |
- |
-88.96% |
Fibrogen Inc |
3 Q |
89.43% |
-158.51% |
-78.91% |
- |
Foghorn Therapeutics Inc |
4 Q |
- |
-417.85% |
- |
- |
Homology Medicines Inc |
3 Q |
- |
- |
- |
-97.6% |
Flora Growth Corp |
3 Q |
28.54% |
6.48% |
0.81% |
0% |
Amicus Therapeutics inc |
4 Q |
89.59% |
-29.22% |
-13.98% |
-119.46% |
Frequency Therapeutics Inc |
3 Q |
- |
- |
- |
-115.97% |
F star Therapeutics Inc |
3 Q |
- |
-1636.18% |
-1470.4% |
-56.71% |
Fulcrum Therapeutics Inc |
3 Q |
- |
-3164.3% |
-511.99% |
-38.48% |
First Wave Biopharma Inc |
3 Q |
- |
- |
- |
412.15% |
Galectin Therapeutics Inc |
3 Q |
- |
- |
- |
- |
Gain Therapeutics inc |
3 Q |
- |
- |
- |
-169.47% |
Generation Bio Co |
4 Q |
- |
-1222.59% |
-931.72% |
-52.29% |
Global Blood Therapeutics Inc. |
2 Q |
98.03% |
-115.26% |
-182.63% |
-170.37% |
The Greater Cannabis Company Inc |
2 Q |
- |
- |
- |
- |
Geron Corp |
3 Q |
- |
-27320.12% |
-15971.34% |
-70.26% |
Gh Research Plc |
4 Q |
- |
- |
- |
-16.25% |
Guardion Health Sciences Inc |
3 Q |
59.35% |
15.15% |
-28.81% |
-117.06% |
Galmed Pharmaceuticals Ltd |
4 Q |
- |
- |
- |
133.1% |
Galapagos Nv |
4 Q |
97.61% |
-43.14% |
0% |
-4.09% |
Gelesis Holdings Inc |
2 Q |
55.01% |
-693.86% |
- |
- |
Greenwich Lifesciences Inc |
1 Q |
- |
- |
- |
-7.58% |
Galecto Inc |
3 Q |
- |
- |
- |
-95.14% |
Glycomimetics Inc |
3 Q |
- |
- |
- |
-96.33% |
Genelux Corporation |
1 Q |
- |
-6096.47% |
- |
- |
Genprex Inc |
3 Q |
- |
- |
- |
-194.71% |
Gossamer Bio Inc |
4 Q |
- |
- |
- |
-944.79% |
Geovax Labs Inc |
3 Q |
- |
- |
- |
-125.46% |
Structure Therapeutics Inc |
4 Q |
- |
- |
- |
-32.69% |
Gracell Biotechnologies Inc |
4 Q |
- |
- |
- |
-44.16% |
Grifols Sa |
4 Q |
- |
- |
- |
3.21% |
Gri Bio Inc |
3 Q |
- |
- |
- |
-595.6% |
Galera Therapeutics Inc |
3 Q |
- |
- |
- |
- |
Globestar Therapeutics Corporation |
4 Q |
- |
- |
- |
- |
Gt Biopharma Inc |
3 Q |
- |
- |
- |
-87.8% |
G1 Therapeutics Inc |
4 Q |
- |
-73.14% |
-137.19% |
-106.04% |
Hutchmed china Limited |
4 Q |
60.38% |
12.06% |
-14.21% |
13.6% |
Hcw Biologics Inc |
3 Q |
20.49% |
-578.9% |
- |
-64.43% |
Hepion Pharmaceuticals inc |
3 Q |
- |
- |
- |
-137.96% |
Humanigen Inc |
1 Q |
- |
-1892.31% |
-3194.12% |
- |
Hookipa Pharma inc |
3 Q |
- |
-277.65% |
-404.78% |
-70.24% |
Hoth Therapeutics Inc |
3 Q |
- |
-37187.36% |
- |
-102.76% |
Werewolf Therapeutics Inc |
4 Q |
- |
-799.67% |
- |
-32.25% |
Inhibitor Therapeutics Inc |
2 Q |
- |
- |
- |
229.02% |
Harmony Biosciences Holdings inc |
4 Q |
74.35% |
15.79% |
-7.67% |
27.47% |
Harrow Inc |
3 Q |
70.76% |
-12.84% |
- |
-38.87% |
Heron Therapeutics Inc |
3 Q |
42.36% |
-80.09% |
68.52% |
- |
Hst Global Inc |
3 Q |
- |
- |
- |
- |
Histogen Inc |
3 Q |
- |
-77080% |
-53720% |
-136.2% |
Fsd Pharma Inc |
4 Q |
- |
- |
- |
-77.29% |
Horizon Therapeutics Public Limited Company |
2 Q |
76.8% |
13.46% |
16.21% |
8.54% |
Ibio inc |
3 Q |
- |
-11492% |
-5636% |
-324.84% |
Intercept Pharmaceuticals inc |
3 Q |
99.78% |
-3.14% |
-37.96% |
-82.24% |
Ideaya Biosciences Inc |
3 Q |
- |
-341.38% |
- |
-24.39% |
Inflarx N v |
4 Q |
- |
- |
- |
-33.37% |
Igc Pharma Inc |
4 Q |
65.2% |
-2739.71% |
-807.84% |
-110.37% |
Igm Biosciences Inc |
3 Q |
- |
-12178.59% |
- |
-91.73% |
Intelgenx Technologies Corp |
3 Q |
- |
-867.61% |
-202.52% |
- |
I mab |
4 Q |
- |
- |
- |
-86.16% |
Immunogen inc |
3 Q |
- |
27.11% |
29.58% |
-22.11% |
Imago Biosciences Inc |
3 Q |
- |
- |
- |
-13.66% |
Immutep Limited |
2 Q |
- |
-767.22% |
- |
-29.23% |
Immix Biopharma Inc |
2 Q |
- |
- |
- |
-45.4% |
Immunome Inc |
3 Q |
- |
-121.88% |
- |
-253.18% |
Imunon Inc |
3 Q |
- |
- |
- |
-116.61% |
Impel Pharmaceuticals Inc |
3 Q |
58.27% |
-288.21% |
-217.42% |
- |
Immuron Limited |
2 Q |
88.43% |
-255.78% |
- |
-19.3% |
Immuneering Corporation |
4 Q |
- |
- |
- |
-52.49% |
Biostax Corp |
3 Q |
- |
- |
- |
- |
Immunic Inc |
4 Q |
- |
- |
- |
-157.44% |
Integrated Biopharma Inc |
4 Q |
4.94% |
-3.63% |
-17.7% |
-2.05% |
Intercure Ltd |
4 Q |
39.9% |
11.26% |
9.75% |
8.39% |
Indaptus Therapeutics Inc |
4 Q |
- |
- |
- |
-81.61% |
Indivior Plc |
4 Q |
82.98% |
0.18% |
0% |
- |
Infinity Pharmaceuticals Inc |
2 Q |
- |
-1707.72% |
- |
- |
Inmed Pharmaceuticals Inc |
4 Q |
26.14% |
-119.19% |
- |
-77.75% |
Insmed Inc |
4 Q |
78.47% |
-217.2% |
-5.53% |
- |
Inozyme Pharma Inc |
3 Q |
- |
- |
- |
-55.93% |
Io Biotech Inc |
3 Q |
- |
- |
- |
-60.91% |
Ionis Pharmaceuticals Inc |
4 Q |
99.77% |
2.79% |
12.45% |
-63.15% |
Immunoprecise Antibodies Ltd |
1 Q |
55.95% |
-128.53% |
0% |
-45.95% |
Intellipharmaceutics International Inc |
4 Q |
- |
-4400.55% |
- |
- |
Disc Medicine Inc |
3 Q |
- |
- |
- |
-26% |
Ironwood Pharmaceuticals inc |
4 Q |
- |
-1.48% |
-16.42% |
- |
International Stem Cell Corporation |
3 Q |
60.42% |
-6.64% |
2.43% |
- |
Iveric Bio Inc |
1 Q |
- |
- |
- |
-57% |
Intra cellular Therapies Inc |
4 Q |
- |
-21.63% |
36.61% |
-23.02% |
Iterum Therapeutics Plc |
3 Q |
- |
-29.37% |
-67.57% |
-216.28% |
Inventiva S a |
4 Q |
- |
-445.64% |
- |
-109.15% |
Incannex Healthcare Inc |
4 Q |
- |
- |
- |
- |
Jaguar Health inc |
3 Q |
81.73% |
-280.98% |
-192% |
-1205.31% |
Janone Inc |
3 Q |
- |
- |
- |
101.35% |
Janux Therapeutics Inc |
3 Q |
- |
-459.59% |
-657.57% |
-19.56% |
Jazz Pharmaceuticals Plc |
4 Q |
- |
9.3% |
16.86% |
11.78% |
Johnson and Johnson |
4 Q |
75.32% |
29.92% |
15.75% |
48.95% |
Kineta Inc |
3 Q |
- |
- |
- |
-1994.91% |
Kala Bio inc |
3 Q |
- |
- |
- |
-260.94% |
Kalvista Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-67.13% |
Chinook Therapeutics Inc |
2 Q |
- |
-6641.27% |
- |
-58.28% |
Kamada Ltd |
4 Q |
38.94% |
5.81% |
0% |
3.39% |
Kiniksa Pharmaceuticals ltd |
4 Q |
88.51% |
30.26% |
-11.84% |
3.42% |
Kinnate Biopharma Inc |
3 Q |
- |
- |
- |
-62.31% |
Kiora Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-117.7% |
Karyopharm Therapeutics Inc |
3 Q |
97.47% |
-95.83% |
-103.49% |
- |
Kronos Bio Inc |
3 Q |
- |
-3421.37% |
-2003.71% |
-55.93% |
Keros Therapeutics Inc |
4 Q |
- |
-270.12% |
- |
-46.74% |
Karuna Therapeutics Inc |
3 Q |
- |
- |
- |
-29.58% |
Kintara Therapeutics Inc |
3 Q |
- |
- |
- |
-573.13% |
Pasithea Therapeutics Corp |
3 Q |
- |
- |
- |
-44.04% |
Kura Oncology Inc |
3 Q |
- |
- |
- |
-33.54% |
Kazia Therapeutics Limited |
2 Q |
- |
-2046500% |
- |
-169.83% |
Kezar Life Sciences Inc |
3 Q |
- |
-330.04% |
-23.01% |
-36.18% |
Longboard Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-83.25% |
Lannett Company Inc |
1 Q |
19.1% |
-127.69% |
-11.72% |
- |
Lexaria Bioscience Corp |
4 Q |
96.81% |
-783.35% |
- |
-214.52% |
Lifevantage Corp |
4 Q |
78.66% |
-1.27% |
-2.08% |
9.5% |
Ligand Pharmaceuticals Incorporated |
3 Q |
74.94% |
-31.26% |
-26.13% |
2.56% |
Longeveron Inc |
3 Q |
36% |
-3404% |
-520% |
-147.9% |
Lianbio |
3 Q |
- |
- |
- |
-0.33% |
Lftd Partners Inc |
3 Q |
33.74% |
4.71% |
7.88% |
7.41% |
Lipella Pharmaceuticals Inc |
4 Q |
- |
-570.07% |
- |
-150.11% |
Lixte Biotechnology Holdings Inc |
3 Q |
- |
- |
- |
-134.89% |
Eli Lilly And Company |
4 Q |
80.88% |
23.41% |
4.68% |
46.98% |
Landec Corporation |
1 Q |
26.27% |
-24.29% |
1.44% |
-36.52% |
Lipocine Inc |
4 Q |
- |
-2519.07% |
- |
-63.28% |
Leap Therapeutics inc |
4 Q |
- |
- |
- |
-133.17% |
Liquidia Corporation |
4 Q |
78.08% |
-605.83% |
- |
-132.16% |
Larimar Therapeutics Inc |
3 Q |
- |
- |
- |
-32.58% |
Lucy Scientific Discovery Inc |
4 Q |
60.06% |
-27050.05% |
-273.59% |
-109.81% |
Lantern Pharma Inc |
2 Q |
- |
- |
- |
-26.42% |
Lumos Pharma Inc |
4 Q |
- |
-1144.92% |
-57.99% |
-85.63% |
Lexicon Pharmaceuticals Inc |
3 Q |
95.68% |
-31188.27% |
-50095.68% |
-118.9% |
Lyell Immunopharma Inc |
4 Q |
- |
-407153.85% |
-1081276.92% |
-32.66% |
Merrimack Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-15.88% |
Maia Biotechnology Inc |
3 Q |
- |
- |
- |
-91.44% |
Mustang Bio inc |
3 Q |
- |
- |
- |
-133.38% |
Moleculin Biotech Inc |
3 Q |
- |
- |
- |
-60.64% |
Seres Therapeutics Inc |
3 Q |
- |
-15436.77% |
-19228.71% |
- |
Madrigal Pharmaceuticals Inc |
4 Q |
- |
- |
- |
-219.39% |
Medicenna Therapeutics Corp. |
1 Q |
- |
- |
- |
- |
23andme Holding Co |
4 Q |
45.38% |
-632.68% |
-31.79% |
-87.29% |
Mei Pharma Inc |
3 Q |
- |
86.33% |
-20.73% |
87.24% |
Macrogenics Inc |
4 Q |
98.48% |
-429.78% |
- |
-5.77% |
Mira Pharmaceuticals Inc |
2 Q |
- |
- |
- |
- |
Mirum Pharmaceuticals Inc |
3 Q |
- |
-49.42% |
12.22% |
-104.1% |
Milestone Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-125.27% |
Moonlake Immunotherapeutics |
4 Q |
- |
- |
- |
-11.29% |
Mineralys Therapeutics Inc |
3 Q |
- |
- |
- |
- |
Mallinckrodt Plc |
3 Q |
30.35% |
-347.18% |
-11.8% |
-453.63% |
Mannkind Corporation |
3 Q |
79.98% |
3.36% |
-6.18% |
- |
Medicinova Inc |
3 Q |
- |
-72.31% |
-136.89% |
-14.21% |
Monopar Therapeutics Inc |
3 Q |
- |
- |
- |
-113.31% |
Morphosys Ag |
4 Q |
75.51% |
-79.63% |
46.08% |
-386.82% |
Morphic Holding inc |
4 Q |
- |
- |
- |
-23.62% |
Medicure Inc |
4 Q |
69.69% |
5.92% |
11.78% |
6.5% |
Mereo Biopharma Group Plc |
4 Q |
- |
- |
- |
20.57% |
Merck and Co Inc |
3 Q |
73.29% |
29.76% |
18.53% |
10.67% |
Marker Therapeutics inc |
3 Q |
- |
-1157.57% |
-251.62% |
-52.15% |
Marinus Pharmaceuticals Inc |
3 Q |
93.8% |
-449.33% |
- |
-169.08% |
Mersana Therapeutics Inc |
4 Q |
- |
-182.64% |
-109.54% |
-282.36% |
Mirati Therapeutics Inc |
3 Q |
- |
-987.22% |
- |
-82.15% |
Merus N v |
3 Q |
- |
-208.57% |
- |
-63.39% |
Maravai Lifesciences Holdings Inc |
3 Q |
45.13% |
-22.59% |
-0.85% |
6.57% |
Musclepharm Corporation |
1 Q |
11.52% |
-48.1% |
-5.26% |
- |
Metacrine Inc |
3 Q |
- |
- |
- |
-83.77% |
Molecular Templates inc |
3 Q |
- |
61.11% |
- |
- |
Matinas Biopharma Holdings Inc |
2 Q |
- |
- |
- |
-58.38% |
Mural Oncology Plc |
3 Q |
- |
- |
- |
- |
Mainz Biomed N v |
4 Q |
34.38% |
-4979.9% |
0% |
-187.2% |
Myovant Sciences Ltd |
4 Q |
92.6% |
-57.5% |
-95.85% |
- |
Innovation1 Biotech Inc |
3 Q |
- |
- |
- |
-3806.7% |
Nature s Sunshine Products inc |
4 Q |
70.8% |
8.45% |
5.73% |
10.81% |
Nascent Biotech Inc |
4 Q |
- |
- |
- |
- |
Nabriva Therapeutics Plc |
2 Q |
-304.55% |
-537.76% |
14.89% |
-2673.17% |
Neubase Therapeutics inc |
3 Q |
- |
- |
- |
-103.52% |
Nanobiotix S a |
4 Q |
- |
-1194.33% |
- |
- |
Novabay Pharmaceuticals Inc |
3 Q |
64.76% |
-61.91% |
-33.19% |
-225.86% |
Nucana Plc |
4 Q |
- |
- |
- |
-105.28% |
Neptune Wellness Solutions Inc |
4 Q |
13.62% |
-252.25% |
-46.29% |
- |
Minerva Neurosciences Inc |
3 Q |
- |
- |
- |
- |
Neximmune Inc |
3 Q |
- |
- |
- |
-216.32% |
Ngm Biopharmaceuticals Inc |
4 Q |
- |
-16769.7% |
- |
-77.85% |
Nighthawk Biosciences inc |
3 Q |
24.63% |
-1979.19% |
-65.57% |
-100.3% |
Nektar Therapeutics |
3 Q |
48.51% |
-189.85% |
58.78% |
-121.87% |
Nkarta Inc |
3 Q |
- |
- |
- |
-36.69% |
Nls Pharmaceutics Ltd |
4 Q |
- |
- |
- |
-502.79% |
Neoleukin Therapeutics Inc |
3 Q |
- |
- |
- |
-24.54% |
9 Meters Biopharma Inc |
1 Q |
- |
- |
- |
-584.98% |
Nanomix Corp |
4 Q |
- |
- |
- |
- |
Nanoviricides inc |
4 Q |
- |
- |
- |
-63.96% |
Novan Inc |
1 Q |
59.41% |
-445.96% |
-5.62% |
-616.76% |
Neurobo Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-53.18% |
Nurix Therapeutics Inc |
4 Q |
- |
-276.77% |
81.29% |
-59.47% |
Nrx Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
Rebus Holdings Inc |
2 Q |
- |
- |
- |
- |
Nuvation Bio Inc |
3 Q |
- |
- |
- |
-13.09% |
Nuvalent Inc |
3 Q |
- |
- |
- |
-26.46% |
Nuvectis Pharma inc |
1 Q |
- |
- |
- |
- |
Novartis Ag |
4 Q |
73.27% |
31.83% |
26.59% |
31.77% |
Northwest Biotherapeutics inc |
3 Q |
- |
-4704.19% |
- |
- |
Nexien Biopharma Inc |
2 Q |
- |
- |
- |
- |
Nextcure Inc |
3 Q |
- |
- |
- |
-44.7% |
Theralink Technologies Inc |
4 Q |
36.93% |
-22688.34% |
-1159.89% |
- |
Obseva Sa |
4 Q |
- |
-107.3% |
-255.45% |
0% |
Oculis Holding Ag |
4 Q |
- |
-4243.2% |
0% |
- |
Ocular Therapeutix Inc |
4 Q |
90.64% |
-197.41% |
- |
-288.91% |
Ocuphire Pharma Inc |
3 Q |
- |
46.59% |
19.88% |
65.54% |
Oragenics Inc |
2 Q |
- |
-23175.46% |
- |
-104.87% |
Organigram Holdings Inc |
3 Q |
21.65% |
-9.8% |
0% |
-5.26% |
Organon and Co |
4 Q |
57.26% |
34.17% |
17.46% |
- |
Olema Pharmaceuticals inc |
3 Q |
- |
- |
- |
-47.48% |
Omeros Corp |
3 Q |
- |
- |
- |
54.32% |
Oncorus Inc |
1 Q |
- |
- |
- |
-134.31% |
Oncosec Medical Incorporated |
4 Q |
- |
- |
- |
-868.37% |
Oncternal Therapeutics Inc |
3 Q |
- |
-5509.5% |
-506.7% |
-85.29% |
Oncolytics Biotech Inc |
4 Q |
- |
- |
- |
-100.69% |
Onconova Therapeutics inc |
3 Q |
- |
-8314.04% |
-7868.42% |
-87.66% |
Opko Health Inc |
3 Q |
40.44% |
-47.3% |
17.09% |
-13.63% |
Opiant Pharmaceuticals Inc |
3 Q |
- |
-5703.35% |
-2759.19% |
-97.18% |
Optinose Inc |
4 Q |
89.27% |
-49.91% |
34.43% |
- |
Organogenesis Holdings Inc |
3 Q |
76.24% |
2.92% |
8.58% |
4.45% |
Orgenesis Inc |
2 Q |
53.66% |
52.49% |
-36.17% |
37.77% |
Oric Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-39.61% |
Oramed Pharmaceuticals Inc |
3 Q |
- |
- |
- |
10.27% |
Otonomy Inc |
3 Q |
- |
- |
- |
-137.86% |
Oncotelic Therapeutics Inc |
3 Q |
- |
58.66% |
- |
-103.77% |
Ovid Therapeutics Inc |
4 Q |
- |
-10823.47% |
-21471.07% |
-49.76% |
One World Products Inc |
3 Q |
28.18% |
-2971.89% |
-50.29% |
- |
Phibro Animal Health Corporation |
4 Q |
31.49% |
0.51% |
-4.08% |
5.39% |
Prestige Consumer Healthcare Inc |
4 Q |
56.02% |
43.49% |
1.26% |
-5.12% |
Panbela Therapeutics Inc |
3 Q |
- |
- |
- |
- |
Puma Biotechnology Inc |
3 Q |
76.33% |
10.33% |
38.84% |
12.75% |
Rapid Therapeutic Science Laboratories Inc |
2 Q |
- |
- |
- |
- |
Pacira Biosciences inc |
3 Q |
75.75% |
6.62% |
7.51% |
0.88% |
Processa Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-233.27% |
Procyon Corporation |
4 Q |
78.06% |
-20.21% |
-11.22% |
-11.73% |
Pds Biotechnology Corp |
3 Q |
- |
- |
- |
-144.23% |
Pepgen Inc |
3 Q |
- |
- |
- |
-47.97% |
Pfizer Inc |
4 Q |
46.93% |
-23.58% |
-2.22% |
2.23% |
Precigen Inc |
3 Q |
-11.46% |
-1435.46% |
-479.84% |
-54.48% |
Pharming Group N v |
4 Q |
91.46% |
6.65% |
99.77% |
7.82% |
Phasebio Pharmaceuticals Inc. |
2 Q |
- |
-8012.02% |
-5232.69% |
- |
Phathom Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
Phio Pharmaceuticals Corp |
3 Q |
- |
- |
- |
-132.27% |
Pharvaris N v |
4 Q |
- |
- |
- |
-28.63% |
Pieris Pharmaceuticals Inc |
3 Q |
- |
-55.08% |
-61.7% |
-98.12% |
Peak Pharmaceuticals Inc |
4 Q |
- |
- |
- |
- |
Protokinetix Incorporated |
3 Q |
- |
- |
- |
-413.38% |
Pliant Therapeutics Inc |
3 Q |
- |
- |
- |
-32.5% |
Plx Pharma Inc |
3 Q |
-278.24% |
-2201.3% |
-2563.73% |
-114.93% |
Promis Neurosciences inc |
3 Q |
- |
- |
- |
- |
Pmv Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-31.15% |
Point Biopharma Global Inc |
3 Q |
- |
-887.97% |
-1279.07% |
21.1% |
Purple Biotech Ltd |
4 Q |
- |
- |
- |
46.2% |
Propanc Biopharma Inc |
2 Q |
- |
- |
- |
- |
Praxis Precision Medicines Inc |
4 Q |
- |
-5219.03% |
-3841.75% |
-151.02% |
Pardes Biosciences Inc |
2 Q |
- |
- |
- |
-43.36% |
Perrigo Company Plc |
4 Q |
36.9% |
-2.79% |
13.21% |
-0.26% |
Prelude Therapeutics Inc |
3 Q |
- |
- |
- |
-14.66% |
Procaps Group S a |
4 Q |
58.44% |
10.38% |
0% |
- |
Prophase Labs Inc |
3 Q |
27.95% |
-61.74% |
-37.49% |
-17.51% |
Proqr Therapeutics N v |
4 Q |
- |
- |
- |
0% |
Prothena Corporation Public Limited Company |
4 Q |
- |
-21353.16% |
-16476.9% |
-24.84% |
Puretech Health Plc |
4 Q |
- |
-237.32% |
- |
-6.77% |
Portage Biotech Inc. |
1 Q |
- |
- |
- |
-12.99% |
Paratek Pharmaceuticals Inc |
1 Q |
80.01% |
-64.49% |
34.51% |
- |
Provention Bio Inc |
4 Q |
- |
-307.75% |
-539.56% |
-103.36% |
Ptc Therapeutics inc |
4 Q |
- |
-50.74% |
- |
- |
Protagonist Therapeutics inc |
4 Q |
- |
45.56% |
-73% |
-27.49% |
Protagenic Therapeutics Inc new |
2 Q |
- |
- |
- |
-40.73% |
Palatin Technologies Inc |
4 Q |
95.2% |
-385.62% |
- |
- |
Petros Pharmaceuticals inc |
3 Q |
75.61% |
-271.67% |
- |
- |
Pulmatrix Inc |
2 Q |
- |
-345.23% |
-347.78% |
-57.48% |
Provectus Biopharmaceuticals Inc |
3 Q |
- |
-1112.59% |
73.2% |
- |
Powerup Acquisition Corp |
4 Q |
- |
- |
- |
- |
Paxmedica Inc |
4 Q |
- |
- |
- |
-956.79% |
Pyxis Oncology Inc |
3 Q |
- |
- |
- |
-63.26% |
Q Biomed inc |
1 Q |
- |
- |
- |
- |
Qualigen Therapeutics Inc |
3 Q |
- |
- |
- |
-477.12% |
Qilian International Holding Group Limited |
3 Q |
3.83% |
-17.75% |
1.62% |
-18.31% |
Uniqure N v |
3 Q |
- |
-6366.1% |
-20194.46% |
-60.49% |
Rain Oncology Inc |
3 Q |
- |
- |
- |
-82.96% |
Rani Therapeutics Holdings Inc |
3 Q |
- |
- |
- |
-130.24% |
Rapt Therapeutics Inc |
3 Q |
- |
- |
- |
-51.96% |
Ultragenyx Pharmaceutical Inc |
3 Q |
88.79% |
-162.82% |
-29.64% |
-346.34% |
Actavia Life Sciences Inc |
4 Q |
- |
-36097.07% |
-13643.77% |
- |
Rocket Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-53.4% |
Arcus Biosciences Inc |
4 Q |
- |
-261.29% |
-183.87% |
-57.17% |
Redhill Biopharma Ltd |
4 Q |
46.06% |
- |
47.4% |
- |
Dr Reddy s Laboratories Limited |
1 Q |
56.65% |
18.32% |
0% |
19.5% |
Regeneron Pharmaceuticals Inc |
4 Q |
91.07% |
33.77% |
16.82% |
16.07% |
Renovaro Inc |
4 Q |
- |
- |
- |
-81.25% |
Reata Pharmaceuticals Inc |
2 Q |
- |
- |
-158.7% |
- |
Revelation Biosciences Inc |
3 Q |
- |
- |
- |
11.18% |
Regen Biopharma Inc |
4 Q |
- |
-1105.44% |
10.94% |
- |
Regulus Therapeutics Inc |
3 Q |
- |
- |
- |
-90.69% |
Regenerx Biopharmaceuticals inc |
1 Q |
- |
-2007.3% |
-986.62% |
- |
Rigel Pharmaceuticals Inc |
3 Q |
95.49% |
-20.23% |
-12.08% |
- |
Relmada Therapeutics Inc |
3 Q |
- |
- |
- |
-93.37% |
Rallybio Corporation |
4 Q |
- |
- |
- |
-56.9% |
Rockwell Medical inc |
3 Q |
9.49% |
-8.07% |
-5.17% |
-61.48% |
Avidity Biosciences Inc |
4 Q |
- |
-2756.18% |
- |
-39.74% |
Cartesian Therapeutics Inc |
4 Q |
- |
- |
- |
- |
Transcode Therapeutics Inc |
3 Q |
- |
- |
- |
-821.81% |
Renovorx Inc |
3 Q |
- |
- |
- |
-345.27% |
Roivant Sciences Ltd |
4 Q |
- |
- |
- |
160.44% |
Reneo Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-62.08% |
Royalty Pharma Plc |
4 Q |
- |
- |
-77.08% |
17.3% |
Repare Therapeutics Inc |
3 Q |
- |
-874.43% |
-378.65% |
-38.6% |
Respirerx Pharmaceuticals Inc |
2 Q |
- |
- |
- |
- |
Rvl Pharmaceuticals Plc |
2 Q |
86.32% |
-326.71% |
-184.37% |
-155.18% |
Revance Therapeutics Inc |
4 Q |
77.91% |
- |
-60.16% |
- |
Reviva Pharmaceuticals Holdings Inc |
3 Q |
- |
- |
- |
-1344.44% |
Prometheus Biosciences Inc |
1 Q |
- |
-3699.19% |
-19388.87% |
-33.5% |
Rhythm Pharmaceuticals inc |
3 Q |
89.28% |
-196.25% |
-227.03% |
-94.1% |
Rayzebio Inc |
3 Q |
- |
- |
- |
- |
Rezolute Inc |
4 Q |
- |
- |
- |
-51.81% |
Sage Therapeutics Inc |
3 Q |
66.68% |
-7423.78% |
- |
-62.67% |
Cassava Sciences Inc |
4 Q |
- |
- |
- |
-57.53% |
Sunshine Biopharma Inc |
3 Q |
33.41% |
-10.94% |
-8.43% |
-111.3% |
Scpharmaceuticals Inc |
3 Q |
71.58% |
-411.85% |
-956.48% |
-77.06% |
Scopus Biopharma Inc |
2 Q |
- |
- |
- |
- |
Societal Cdmo Inc |
3 Q |
15.77% |
-19.47% |
14.64% |
-37.93% |
Scynexis Inc |
3 Q |
- |
-99.77% |
-788.64% |
182.33% |
Schrodinger Inc |
4 Q |
77.68% |
-41.4% |
-127.62% |
7.04% |
Seelos Therapeutics inc |
4 Q |
- |
-820% |
61.95% |
- |
Sangui Biotech International Inc |
1 Q |
- |
-205.74% |
-12.47% |
- |
Sagimet Biosciences inc |
3 Q |
- |
-317.65% |
- |
- |
Sigilon Therapeutics Inc |
2 Q |
- |
-127.22% |
-366.66% |
-83.83% |
Shuttle Pharmaceuticals Holdings Inc |
4 Q |
- |
- |
- |
-156.17% |
Siga Technologies Inc |
4 Q |
87.29% |
62.03% |
67.85% |
44.84% |
Sio Gene Therapies Inc |
4 Q |
- |
- |
- |
-55.94% |
Skinvisible Inc |
3 Q |
- |
-5750.36% |
-56.34% |
- |
Skye Bioscience Inc |
3 Q |
- |
- |
- |
- |
Sol gel Technologies Ltd |
4 Q |
- |
-1752.77% |
- |
-70.48% |
Acelyrin Inc |
3 Q |
- |
- |
- |
- |
Salarius Pharmaceuticals inc |
3 Q |
- |
- |
- |
-236.94% |
Sellas Life Sciences Group Inc |
3 Q |
- |
- |
- |
-805.32% |
Summit Therapeutics Inc |
4 Q |
- |
- |
- |
-571.82% |
Syndax Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-42.37% |
Soligenix inc |
4 Q |
9.5% |
-743.38% |
-756.65% |
-268.25% |
Sonoma Pharmaceuticals Inc |
4 Q |
46.53% |
-27.6% |
8.57% |
-73.6% |
Synaptogenix Inc |
3 Q |
- |
- |
- |
34.96% |
Sensei Biotherapeutics Inc |
3 Q |
- |
- |
- |
-44.68% |
Sanofi |
4 Q |
69.35% |
11.7% |
21.74% |
7.31% |
Sonnet Biotherapeutics Holdings Inc |
4 Q |
- |
-6273.54% |
- |
-1067.83% |
Spectrum Pharmaceuticals Inc |
1 Q |
93.19% |
-32.07% |
76.88% |
-209.59% |
Spruce Biosciences Inc |
3 Q |
- |
-402.02% |
42.92% |
-54.81% |
Scisparc Ltd |
4 Q |
76.1% |
- |
- |
40.19% |
Spero Therapeutics Inc |
3 Q |
- |
-12.58% |
63.34% |
-2.59% |
Ars Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-7.83% |
Sarepta Therapeutics Inc |
3 Q |
- |
-12.34% |
-93.39% |
-106.15% |
Sierra Oncology Inc |
1 Q |
- |
- |
- |
-76.49% |
Statera Biopharma Inc fka Cytocom Inc |
3 Q |
74.74% |
-500.68% |
0% |
- |
Stoke Therapeutics Inc |
3 Q |
- |
-741.9% |
-62.97% |
-54.29% |
Satsuma Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-115.24% |
Shattuck Labs Inc |
3 Q |
- |
-4014.72% |
-4557% |
-64.97% |
Supernus Pharmaceuticals inc |
3 Q |
87.26% |
-10.38% |
45.67% |
2.82% |
Sunwin Stevia International Inc. |
2 Q |
14.99% |
-2.52% |
8.06% |
-106.36% |
Sinovac Biotech Ltd |
4 Q |
54.15% |
5.9% |
- |
0.69% |
Savara Inc |
3 Q |
- |
- |
- |
-44.42% |
60 Degrees Pharmaceuticals Inc |
2 Q |
-209.04% |
-5616.46% |
-412.88% |
- |
Synlogic Inc |
3 Q |
- |
-3073.28% |
-5527.99% |
-95.3% |
Spyre Therapeutics Inc |
4 Q |
- |
- |
- |
- |
Syros Pharmaceuticals Inc |
3 Q |
- |
-1067.07% |
-85.67% |
-122.04% |
Takeda Pharmaceutical Company Limited |
1 Q |
69.11% |
7.87% |
20.57% |
4.99% |
Taro Pharmaceutical Industries Ltd |
1 Q |
46.83% |
4.44% |
16.03% |
1.47% |
Theravance Biopharma inc |
3 Q |
- |
-57.03% |
-216.09% |
-17.05% |
Tricida Inc |
3 Q |
- |
- |
- |
- |
Alaunos Therapeutics Inc |
3 Q |
- |
- |
- |
-140.74% |
Tenx Keane Acquisition |
4 Q |
- |
- |
- |
0% |
Tenax Therapeutics Inc |
3 Q |
- |
- |
- |
69.85% |
Terns Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-30.99% |
Teva Pharmaceutical Industries Limited |
4 Q |
54.22% |
9.72% |
21.93% |
-7.7% |
Tff Pharmaceuticals Inc |
3 Q |
- |
-1878.17% |
- |
-83.82% |
Tg Therapeutics Inc |
3 Q |
97.88% |
68.71% |
32.5% |
-35.58% |
Tharimmune Inc |
4 Q |
- |
- |
- |
-171.08% |
Third Harmonic Bio Inc |
3 Q |
- |
- |
- |
5.62% |
Thorne Healthtech Inc |
2 Q |
55.89% |
5.96% |
0.87% |
13.58% |
Theseus Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-24.84% |
Theratechnologies Inc |
4 Q |
75.99% |
-29.3% |
47.69% |
- |
Talphera Inc |
4 Q |
- |
- |
- |
- |
Tiziana Life Sciences Ltd |
4 Q |
- |
- |
- |
-78.67% |
Timber Pharmaceuticals Inc |
2 Q |
- |
-29367.95% |
-19196.18% |
-516.88% |
Tango Therapeutics Inc |
3 Q |
- |
-207.45% |
-70.06% |
-41.41% |
Tonix Pharmaceuticals Holding Corp |
3 Q |
40.49% |
-701.3% |
-449.84% |
-67.1% |
Theriva Biologics inc |
3 Q |
- |
- |
- |
-34.16% |
Tempest Therapeutics Inc |
3 Q |
- |
- |
- |
-378.21% |
Turning Point Therapeutics Inc. |
2 Q |
- |
-103435.29% |
-16289.92% |
-37.45% |
Entrada Therapeutics Inc |
4 Q |
- |
-73.49% |
37.56% |
2.32% |
Trevi Therapeutics Inc |
3 Q |
- |
- |
- |
-27.17% |
Trevena inc |
3 Q |
- |
- |
- |
-314.87% |
2seventy Bio Inc |
4 Q |
- |
-531.84% |
-144.63% |
-65.41% |
Travere Therapeutics Inc |
4 Q |
- |
- |
- |
-56.68% |
Therapeuticsmd Inc |
3 Q |
- |
- |
- |
216.13% |
Neuropathix Inc. |
1 Q |
- |
-767.19% |
41.6% |
- |
Tyme Technologies Inc. |
2 Q |
- |
- |
- |
-29.11% |
Tyra Biosciences Inc |
3 Q |
- |
- |
- |
-24.48% |
Unity Biotechnology Inc |
3 Q |
- |
- |
- |
-94.34% |
Unicycive Therapeutics Inc |
3 Q |
- |
- |
- |
- |
Universe Pharmaceuticals Inc |
3 Q |
31.93% |
-19.08% |
-7.32% |
-15.59% |
Urogen Pharma Ltd |
4 Q |
88.59% |
-108.49% |
-101.34% |
- |
United Therapeutics Corporation |
4 Q |
88.45% |
35.32% |
16.27% |
17.72% |
Vaccitech Plc |
2 Q |
- |
-7132.93% |
-5478.44% |
-23.44% |
Avricore Health Inc |
4 Q |
25.83% |
-46.27% |
17.12% |
-41.66% |
Vaxxinity Inc |
3 Q |
- |
- |
- |
-172.68% |
Vbi Vaccines Inc |
3 Q |
- |
-321.65% |
- |
-333.29% |
Vascular Biogenics Ltd |
4 Q |
84.19% |
- |
-1962.31% |
0% |
Vaccinex Inc |
3 Q |
- |
-24560% |
-8905% |
0% |
Vera Therapeutics Inc |
3 Q |
- |
- |
- |
-82.41% |
Veru Inc |
3 Q |
47.54% |
-332.98% |
-203.23% |
-354.59% |
Verve Therapeutics Inc |
3 Q |
- |
-1468.01% |
- |
-38.83% |
Viveon Health Acquisition Corp |
4 Q |
- |
- |
- |
- |
Vincerx Pharma Inc |
3 Q |
- |
- |
- |
-160.15% |
Virios Therapeutics Inc |
4 Q |
- |
- |
- |
28.59% |
Viracta Therapeutics Inc |
3 Q |
- |
- |
- |
-150.26% |
Viking Therapeutics Inc |
3 Q |
- |
- |
- |
-31.28% |
Vanda Pharmaceuticals Inc |
4 Q |
92.36% |
-5.3% |
-104.63% |
0.46% |
Verrica Pharmaceuticals Inc |
3 Q |
- |
-850.26% |
- |
-95.39% |
Verona Pharma Plc |
4 Q |
- |
- |
- |
-20.47% |
Virpax Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-107.65% |
Vertex Pharmaceuticals Inc |
4 Q |
85.38% |
38.48% |
-29.56% |
22.62% |
Verastem inc |
4 Q |
- |
- |
- |
-127% |
Vistagen Therapeutics Inc |
4 Q |
- |
-1543.46% |
- |
-72.12% |
Viatris Inc |
4 Q |
41.6% |
-19.95% |
-8.29% |
0.26% |
Vtv Therapeutics Inc |
4 Q |
- |
- |
- |
- |
Ventyx Biosciences Inc |
3 Q |
- |
- |
- |
-54.28% |
Vyne Therapeutics Inc |
4 Q |
- |
-8142.11% |
- |
-79.06% |
Wellness Center Usa Inc |
2 Q |
90.33% |
-689.92% |
-20.87% |
- |
Wave Life Sciences Ltd |
3 Q |
- |
14.74% |
-67.09% |
- |
Xenetic Biosciences Inc |
3 Q |
- |
-172.71% |
-155.38% |
-36.09% |
Xbiotech Inc |
4 Q |
- |
- |
- |
-10.82% |
Exicure Inc |
2 Q |
- |
- |
- |
34.49% |
Xenon Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-25.99% |
Xeris Biopharma Holdings Inc |
4 Q |
82.95% |
76.38% |
47.54% |
12.25% |
Xilio Therapeutics inc |
3 Q |
- |
- |
- |
-104.69% |
Xencor Inc |
4 Q |
- |
-43.11% |
2.37% |
-18.7% |
Xoma Corporation |
4 Q |
- |
-1395.58% |
- |
-44.17% |
Novaccess Global Inc |
4 Q |
- |
- |
- |
- |
Xtl Biopharmaceuticals Ltd |
4 Q |
- |
- |
- |
-19.55% |
Y mabs Therapeutics inc |
3 Q |
87.31% |
-37.88% |
-6.54% |
-18.28% |
Ys Biopharma Co Ltd |
1 Q |
77.68% |
-21.17% |
0% |
-19.97% |
Zai Lab Limited |
4 Q |
61.66% |
-144.96% |
1.01% |
-37.07% |
Zentalis Pharmaceuticals Inc |
4 Q |
- |
- |
- |
-63.95% |
Zomedica Corp |
3 Q |
81.35% |
-9.16% |
-114.7% |
-5.69% |
Zosano Pharma Corporation |
1 Q |
34.85% |
-25309.85% |
- |
-172.07% |
Zoetis Inc |
4 Q |
67.1% |
23.63% |
12.97% |
48.81% |
Zevra Therapeutics Inc |
3 Q |
95.03% |
-485.15% |
-791.95% |
-54.46% |
Zyversa Therapeutics Inc |
2 Q |
- |
- |
- |
0% |
Zymeworks Inc |
4 Q |
- |
-85.56% |
- |
-26.2% |
Zynerba Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-90.03% |